Stockreport

Germany's BioNTech Sued By Rival Over Covid Jab Formula [Barron's]

BioNTech SE - American Depositary Shares  (BNTX) 
PDF CureVac intends to "assert its intellectual property rights, accumulated over more than two decades of pioneering work in mRNA technology, which contributed to Covid-19 [Read more]